Received Jul 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | FH443 | — |
Bexsero was unintentionally administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 12-year-old male patient who received Men B NVS (Bexsero) (batch number FH443, expiry date 30-SEP-2027) for prophylaxis. On 24-JUN-2025, the patient received the 1st dose of Bexsero. On 24-JUN-2025, immediately after receiving Bexsero, the patient experienced wrong vaccine administered (Verbatim: Bexsero was unintentionally administered). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 01-JUL-2025 A vaccine coordinator reported the administration of a Bexsero vaccine to a patient by a member of the staff. She wanted to know how to proceed after this incident. The reporter wanted to report that Bexsero was unintentionally administered, and no other data was provided, which led to wrong vaccine administered. It was explained that it was administered within the recommended range of age. The Vaccine Administration Facility is the same as Primary Reporter. The reporter consented to follow up.